Virus therapy takes on advanced cancers in first human trial
Disease control
Recruiting now
This early-phase study tests a new treatment called IDOV-Immune, a virus designed to infect and kill cancer cells while boosting the immune system. About 78 adults with advanced solid tumors (like colorectal, lung, or breast cancer) that haven't responded to standard care will re…
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC